High Grade Intraepithelial Neoplasia

2

Review clinical trials related to High Grade Intraepithelial Neoplasia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

This is a phase II double-blind, placebo-controlled study of artesunate ointment for the treatment of HPV-associated vulvar HSIL (usual type vulvar intraepithelial neoplasia 2/3).

Participants needed: 27
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: Frantz Viral Therapeutics, LLCUpdated: Aug 14, 2025Locations: 5
Eligibility criteria

Adult women age ≥ 18 years [+10]

Pregnant and nursing women [+10]

Status: Recruiting

Comparison of pCLE and EB in Gastric Lesion Diagnosis

This is a prospective multicenter comparative study, aiming to compare probe-based confocal laser endomicroscopy (pCLE) and endoscopic biopsies in the diagnosis of the whole specific gastric lesion especially for distinguishing low grade intraepithelial neoplasia (LGIN) from high grade intraepithelial neoplasia (HGIN) and create an endoscopic image database for the follow-up research.

Participants needed: 366
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Huazhong University of Science and TechnologyUpdated: May 7, 2024Locations: 1
Eligibility criteria

Over 18 years old and under 75 years old; [+3]

Patients with advanced gastric cancer or previous gastrectomy; [+4]